ID   RLUN016-2
AC   CVCL_E3PF
SY   RLUN016; RLUN16-2; RLUN16; F_PDO_000124
DR   CancerTools; 160945
RX   PubMed=31137590;
WW   https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Doubling time: 7 days (PubMed=31137590).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=31137590; DOI=10.3390/cells8050481; PMCID=PMC6562414;
RA   Takahashi N., Hoshi H., Higa A., Hiyama G., Tamura H., Ogawa M.,
RA   Takagi K., Goda K., Okabe N., Muto S., Suzuki H., Shimomura K.,
RA   Watanabe S., Takagi M.;
RT   "An in vitro system for evaluating molecular targeted drugs using lung
RT   patient-derived tumor organoids.";
RL   Cells 8:481.1-481.18(2019).
//